GOL announces Monthly Investor Update: Capacity, Cash Consumption and Liquidity prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Punch Newspapers
Sections
Joseph Olaoluwa
Smile Telecoms Holdings Ltd. has announced significant changes in the leadership of the group’s board and management.
The telecommunications group made this known after its board meeting which held on January 15, 2021, according to a statement by its Group Head, Corporate Communications and Marketing, Nicolene Zyl.
The statement titled ‘Smile Telecoms Holdings Ltd. announces significant changes in its leadership,’ and syndicated via APO Group, said two of its directors, Ms Irene Charnley and Mr Mohammad Sharbatly were due for retirement effective January 1.
Commenting on the announcement, Chairman of the Group, Mr Ibrahim Sharbatly, said, “We say farewell to our Founder and Deputy Chairman, Ms Irene Charnley. We wish her all success in her new endeavours.
%;
GOL s net cash burn totaled R$1 million a day in January as travel demand cooled and the low season begins.
SÃO PAULO, Feb. 11, 2021 /PRNewswire/
GOL Linhas Aéreas Inteligentes S.A. (NYSE: GOL and B3: GOLL4), ( GOL or Company ), Brazil s largest airline, today provides its
Investor Update for the month of January of 2021. All information is presented in Brazilian Reais (R$). The information below is
preliminary and
unaudited.
In this period, GOL increased its capacity to an average of 489 flights per day, a 3% increase from an average of 476 flights in December/20. The Company operated approximately 628 daily flights on peak days, serving Customers who flew during the summer vacation. GOL also reached a new record of passengers transported since the beginning of the pandemic with more than 93,000 Customers served in a single day. The Company s consolidated gross revenues for the month were R$810 million and the average load factor was 83.2%, a level consistent